Tirzepatide: Game Changer for Weight Maintenance 💊📉
Mar 07, 2025•3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Tirzepatide & Weight Maintenance 💊📉
A phase 3 clinical trial (SURMOUNT-4) showed that continued use of tirzepatide helps maintain weight loss in adults with obesity.
Participants on tirzepatide lost an extra 5.5%, while those on placebo regained 14%.
✅ 89.5% maintained at least 80% of their weight loss, compared to 16.6% on placebo.
Common side effects were mild gastrointestinal issues 🤢.
Stopping treatment led to significant weight regain, reinforcing the need for long-term therapy. 🔬
For the best experience, listen in Metacast app for iOS or Android